- Home
- FHTX vs AVBC Comparison
FHTX vs AVBC Comparison
Compare FHTX & AVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- AVBC
- Stock Information
- Founded
- FHTX 2015
- AVBC 1869
- Country
- FHTX United States
- AVBC United States
- Employees
- FHTX N/A
- AVBC N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- AVBC
- Sector
- FHTX Health Care
- AVBC
- Exchange
- FHTX Nasdaq
- AVBC Nasdaq
- Market Cap
- FHTX 278.1M
- AVBC 316.2M
- IPO Year
- FHTX 2020
- AVBC N/A
- Fundamental
- Price
- FHTX $4.23
- AVBC $14.92
- Analyst Decision
- FHTX Strong Buy
- AVBC Strong Buy
- Analyst Count
- FHTX 5
- AVBC 1
- Target Price
- FHTX $11.80
- AVBC $18.00
- AVG Volume (30 Days)
- FHTX 270.7K
- AVBC 52.6K
- Earning Date
- FHTX 10-31-2025
- AVBC 10-23-2025
- Dividend Yield
- FHTX N/A
- AVBC N/A
- EPS Growth
- FHTX N/A
- AVBC N/A
- EPS
- FHTX N/A
- AVBC N/A
- Revenue
- FHTX $24,173,000.00
- AVBC $79,463,000.00
- Revenue This Year
- FHTX $42.43
- AVBC N/A
- Revenue Next Year
- FHTX $14.77
- AVBC N/A
- P/E Ratio
- FHTX N/A
- AVBC N/A
- Revenue Growth
- FHTX N/A
- AVBC N/A
- 52 Week Low
- FHTX $2.95
- AVBC $14.00
- 52 Week High
- FHTX $9.70
- AVBC $15.99
- Technical
- Relative Strength Index (RSI)
- FHTX 45.28
- AVBC N/A
- Support Level
- FHTX $3.85
- AVBC N/A
- Resistance Level
- FHTX $4.69
- AVBC N/A
- Average True Range (ATR)
- FHTX 0.33
- AVBC 0.00
- MACD
- FHTX 0.04
- AVBC 0.00
- Stochastic Oscillator
- FHTX 55.77
- AVBC 0.00
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About AVBC Avidia Bancorp Inc.
Avidia Bancorp Inc business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial and industrial loans, one-to four-family residential mortgage loans, and commercial real estate loans.